ENSG logo

Ensign (ENSG)

Profile

Full Name

The Ensign Group, Inc.

Ticker Symbol

ENSG

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Care Facilities

Country

United States

IPO

November 9, 2007

Indexes

Not included

Website

http://ensigngroup.net

Employees

39300

Key Details

Price

$128.18(-0.70%)

Market cap

$7.36B(Mid cap)

Last Dividend

$0.06

TTM Dividend yield

0.19%

Annual revenue

$4.26B(+14.24% YoY)

Annual EPS

$5.12(+40.27% YoY)

PE ratio

25.08

Next earnings date

May 2, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$128.18
ENSG price is $128.18

30-Day Relative Volume

0.59
ENSG 30-day relative volume is 0.59

Price Performance

Price Most recent change

-0.7%
ENSG price was down -0.7% on Apr 16, 2025

Price YTD change

-3.52%
ENSG price is down -3.52% since January 1st

Price 1-year change

+8.79%
ENSG price is up +8.79% year-on-year

Price 3-year change

+50.18%
ENSG price is up +50.18% over the past 3 years

Price Range

Price All-time high

$158.45
ENSG price is currently -19.10% below its historical high of $158.45

Price 3-year low

$70.29
ENSG price is currently +82.36% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$7.36B
ENSG market capitalization is $7.36 billion

Market cap 3-year change

+56.01%
ENSG market capitalization is up +56.01% over the past 3 years

Market cap All-time high

$9.07B
ENSG market capitalization is currently -18.78% below its historical high of $9.07 billion

Market cap sector rank

91.45%
ENSG market capitalization is higher than 91.45% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.97%
ENSG shares outstanding is up +0.97% year-on-year

Shares Outstanding 3-Year Change

+3.88%
ENSG shares outstanding is up +3.88% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.35
ENSG beta is 0.35

200-day SMA

$139.53
ENSG price is currently -8.14% below its 200-day simple moving average

50-day SMA

$129.64
ENSG price is currently -1.13% below its 50-day simple moving average

RSI

47.87
ENSG 14-day relative strength index is 47.87

Volume

0.59
ENSG 30-day relative volume is 0.59

ATR

$4.04
ENSG average true range is $4.04

10-day Historical Volatility

37.80%
ENSG 10-day historical volatility is 37.80%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.06
ENSG last dividend was $0.06 per share, with an ex-dividend date of March 31, 2025

Next Dividend

-
ENSG next dividend has not yet been announced

Dividend per share

Dividend per share

$0.24
ENSG annual dividend per share is $0.24

Dividend per share Sector Rank

11.63%
ENSG annual dividend per share is higher than 11.63% of companies in Healthcare sector

Dividend per share 1-Year Change

+4.3%
ENSG annual dividend per share is up +4.3% year-on-year

Dividend per share 3-Year Change

+14.12%
ENSG annual dividend per share is up +14.12% over the past 3 years

Dividend yield

Dividend yield

0.19%
ENSG annual dividend yield is 0.19%

Dividend yield Sector Rank

0%
ENSG annual dividend yield is higher than 0% of companies in Healthcare sector

Other

Payout ratio

4.59%
ENSG annual payout ratio is 4.59%

Dividends paid

$13.67M
ENSG annual dividends paid is $13.67 million

Free cash flow

$188.95M
ENSG annual free cash flow is $188.95 million

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$4.26B
ENSG annual revenue is $4.26 billion

Revenue Analysts estimate

$4.87B
ENSG annual revenue is currently -12.46% lower than the consensus analysts' forecast

Revenue 1-year change

+14.24%
ENSG annual revenue is up +14.24% year-on-year

Revenue Sector rank

91.15%
ENSG annual revenue is higher than 91.15% of companies in Healthcare sector

EPS

EPS

$5.12
ENSG annual earnings per share is $5.12

EPS Analysts estimate

$6.25
ENSG annual earnings per share is currently -18.02% lower than the consensus analysts' forecast

EPS 1-year change

+40.27%
ENSG annual earnings per share is up +40.27% year-on-year

EPS Sector rank

95.7%
ENSG annual earnings per share is higher than 95.7% of companies in Healthcare sector

Profit

Gross profit

$667.59M
ENSG annual gross profit is $667.59 million

Gross margin

15.67%
ENSG annual gross profit margin is 15.67%

Operating profit

$358.30M
ENSG annual operating income is $358.30 million

Operating margin

8.41%
ENSG annual operating profit margin is 8.41%

Net income

$297.97M
ENSG annual net profit is $297.97 million

Net margin

6.99%
ENSG annual net profit margin is 6.99%

Expenses

Total expenses

$3.90B
ENSG annual total expenses is $3.90 billion

Operating expenses

$309.28M
ENSG annual total operating expenses is $309.28 million

Cost of goods sold

$3.59B
ENSG annual cost of goods sold is $3.59 billion

Selling, general & administrative expenses

$225.14M
ENSG annual SGA is $225.14 million

Depreciation and amortization

$84.14M
ENSG annual depreciation & amortization is $84.14 million

Interest expense

$8.29M
ENSG annual interest expense is $8.29 million

Income tax

$87.64M
ENSG annual income tax is $87.64 million

EBIT & EBITDA

EBIT

$394.38M
ENSG annual earnings before interest & taxes is $394.38 million

EBITDA

$478.52M
ENSG annual EBITDA is $478.52 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$4.67B
ENSG annual total assets is $4.67 billion

Non current assets

$3.51B
ENSG annual long term assets is $3.51 billion

Current assets

$1.16B
ENSG annual total current assets is $1.16 billion

Cash and cash equivalents

$464.60M
ENSG annual cash & cash equivalents is $464.60 million

Accounts receivable

$569.90M
ENSG annual accounts receivable is $569.90 million

Inventory

-
ENSG annual inventory value is unknown

Liabilities

Total liabilities

$2.83B
ENSG annual total liabilities is $2.83 billion

Long term liabilities

$2.09B
ENSG annual total long term liabilities is $2.09 billion

Current liabilities

$743.43M
ENSG annual total current liabilities is $743.43 million

Accounts payable

$98.95M
ENSG annual accounts payable is $98.95 million

Debt

Total debt

$1.97B
ENSG annual total debt is $1.97 billion

Total debt 1-year change

+5.51%
ENSG annual total debt is up +5.51% year-on-year

Long term debt

$1.88B
ENSG annual long term debt is $1.88 billion

Short term debt

$97.56M
ENSG annual short term debt is $97.56 million

Equity & Capital

Shareholders equity

$1.84B
ENSG annual stockholders equity is $1.84 billion

Book value

$1.84B
ENSG annual book value is $1.84 billion

Retained earnings

$1.43B
ENSG annual retained earnings is $1.43 billion

Working capital

$414.20M
ENSG annual working capital is $414.20 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$347.19M
ENSG annual cash flow from operations is $347.19 million

Cash from operations 1-year change

-7.83%
ENSG annual cash flow from operations is down -7.83% year-on-year

Cash from investing

-$390.05M
ENSG annual cash flow from investing activities is -$390.05 million

Cash from investing 1-year change

-113.5%
ENSG annual cash flow from investing activities is down -113.5% year-on-year

Cash from financing

-$2.16M
ENSG annual cash flow from financing activities is -$2.16 million

Cash from financing 1-year change

-253.27%
ENSG annual cash flow from financing activities is down -253.27% year-on-year

CAPEX

CAPEX

$158.24M
ENSG annual capital expenditures is $158.24 million

CAPEX 1-year change

+49.03%
ENSG annual capital expenditures is up +49.03% year-on-year

Free Cash Flow

Free cash flow

$188.95M
ENSG annual free cash flow is $188.95 million

Free cash flow 1-year change

-30.15%
ENSG annual free cash flow is down -30.15% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

15.67%
ENSG annual gross profit margin is 15.67%

Operating margin

8.41%
ENSG annual operating profit margin is 8.41%

Net margin

6.99%
ENSG annual net profit margin is 6.99%

ROA & ROE

ROA

6.74%
ENSG annual return on assets is 6.74%

ROE

17.85%
ENSG annual return on equity is 17.85%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

25.08
ENSG price to earnings ratio is 25.08

PE ratio Sector rank

52.94%
ENSG price to earnings ratio is higher than 52.94% of companies in Healthcare sector

PB Ratio

PB ratio

4.01
ENSG price to book ratio is 4.01

PB ratio Sector rank

79.57%
ENSG price to book ratio is higher than 79.57% of companies in Healthcare sector

PS Ratio

PS ratio

1.73
ENSG price to sales ratio is 1.73

PS ratio Sector rank

40.38%
ENSG price to sales ratio is higher than 40.38% of companies in Healthcare sector

Enterprise value

Enterprise value

$8.87B
ENSG enterprise value is $8.87 billion

Enterprise value Sector rank

91.66%
ENSG enterprise value is higher than 91.66% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

18.55
ENSG EV/EBITDA is 18.55

EV/EBITDA Sector rank

90.87%
ENSG EV/EBITDA is higher than 90.87% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.56
ENSG annual current ratio is 1.56

Quick ratio

-
ENSG annual quick ratio value is unknown

Leverage

Debt to equity

0.08
ENSG annual debt to equity ratio is 0.08

Interest coverage ratio

47.60
ENSG annual interest coverage ratio is 47.60

Risk & Stability

Piotroski F-Score

7
ENSG piotroski f-score is 7

Altman Z-Score

3.29
ENSG altman z-score is 3.29

Analyst ratings

Recent major analysts updates

Feb 7, 25 Stephens & Co.
Overweight
Feb 6, 25 Stephens & Co.
Overweight
Feb 4, 25 Macquarie
Outperform
Jan 6, 25 Truist Securities
Hold
Nov 21, 24 UBS
Buy
Oct 28, 24 Truist Securities
Hold
Oct 28, 24 Stephens & Co.
Overweight
Oct 28, 24 RBC Capital
Outperform
Oct 25, 24 Oppenheimer
Outperform
Oct 21, 24 RBC Capital
Outperform

Institutional Ownership

Similar stocks

RGEN logo
Repligen (RGEN)
HALO logo
Halozyme Therapeutics (HALO)
ROIV logo
Roivant Sciences (ROIV)
HQY logo
HealthEquity (HQY)
TEM logo
Tempus AI (TEM)
LNTH logo
Lantheus Holdings (LNTH)
EXAS logo
Exact Sciences (EXAS)
HSIC logo
Henry Schein (HSIC)
BIO logo
Bio-Rad Laboratories (BIO)
  • What is the ticker symbol for Ensign?
  • Does Ensign pay dividends?
  • What sector is Ensign in?
  • What industry is Ensign in?
  • What country is Ensign based in?
  • When did Ensign go public?
  • Is Ensign in the S&P 500?
  • Is Ensign in the NASDAQ 100?
  • Is Ensign in the Dow Jones?
  • When was Ensign's last earnings report?
  • When does Ensign report earnings?
  • Should I buy Ensign stock now?

What is the ticker symbol for Ensign?

The ticker symbol for Ensign is NASDAQ:ENSG

Does Ensign pay dividends?

Yes, Ensign pays dividends. The last payment was $0.06, with an ex-dividend date on March 31, 2025

What sector is Ensign in?

Ensign is in the Healthcare sector

What industry is Ensign in?

Ensign is in the Medical Care Facilities industry

What country is Ensign based in?

Ensign is headquartered in United States

When did Ensign go public?

Ensign's initial public offering (IPO) was on November 9, 2007

Is Ensign in the S&P 500?

No, Ensign is not included in the S&P 500 index

Is Ensign in the NASDAQ 100?

No, Ensign is not included in the NASDAQ 100 index

Is Ensign in the Dow Jones?

No, Ensign is not included in the Dow Jones index

When was Ensign's last earnings report?

Ensign's most recent earnings report was on Feb 5, 2025

When does Ensign report earnings?

The next expected earnings date for Ensign is May 2, 2025

Should I buy Ensign stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page